Uniqure NV (QURE:NASDAQ)
$14.27 3.62 (33.99%)
Analysed Uniqure NV (QURE:NASDAQ) News Sources
uniQure NV (QURE) Q4 2025 Earnings Call Highlights: Breakthroughs and Challenges in Gene Therapy
Yahoo Finance
FDA push for fake Huntington’s brain surgery trial spurs ethical concerns
Orange County Register
UniQure Falls as FDA Seeks Controversial Gene Therapy Study
Bloomberg
US FDA vaccines chief Vinay Prasad set to leave his post next month
Business Standard
Who is Vinay Prasad? US FDA vaccine chief to step down next month
Mint on MSN
Uniqure sinks as FDA demands new trial for Huntington’s gene therapy
BioWorld
UniQure: Q4 Earnings Snapshot
WTOP
FDA Alleges Uniqure Misrepresented Request In Rare-Disease Drug Approval
KFF Health News
UniQure stock plunges after FDA rejects gene therapy data, Sell-side Comments
Investing.com Australia
What is the current price of Uniqure NV (QURE:NASDAQ)?
The current price of Uniqure NV (QURE:NASDAQ) is $14.27.
Uniqure NV (QURE:NASDAQ) absolute price change since previous trading day?
The absolute price change of Uniqure NV (QURE:NASDAQ) since the previous trading day is $3.62.
Uniqure NV (QURE:NASDAQ) percentage price change since previous trading day?
The percentage price change of Uniqure NV (QURE:NASDAQ) since the previous trading day is 33.99%.
What is This Week's average sentiment score for Uniqure NV (QURE:NASDAQ)?
This Week's average sentiment score for Uniqure NV (QURE:NASDAQ) is 28 out of 100.
What is This Week's average sentiment for Uniqure NV (QURE:NASDAQ)?
This Week's sentiment for Uniqure NV (QURE:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.